Parkinson’s Disease Research Study
Individuals with newly diagnosed Parkinson’s Disease and healthy controls are being recruited to participate in The Parkinson’s Progression Markers Initiative (PPMI), the first-ever large-scale study exclusively focused on identifying and validating Parkinson’s Disease biomarkers. The study is sponsored by The Michael J. Fox Foundation for Parkinson’s Research.
Currently, Parkinson’s patients only have treatments that temporarily alleviate symptoms. If a biomarker is found through PPMI, researchers will have a critical tool to aid the quest for disease-modifying therapies that can slow or stop the progression of the disease.
PPMI can’t get started without volunteers. The study will be carried out over five years at 19 clinics in the United States and Europe. Johns Hopkins needs 20 people who have been diagnosed with Parkinson’s but who have not yet started taking medication, and 10 who do not have Parkinson’s or other neurologic conditions.
To learn more, please visit www.michaeljfox.org/PPMI or contact Arita McCoy at email@example.com or (410) 955-2954
Principal Investigator - Zoltan Mari, M.D. NA_00039232
Thank you very much for this important information.It will be appreciated by the people in need. Wishing you well. God bless you.